Package 76420-053-30

{"route": ["ORAL"], "spl_id": "b26ab5c7-62e8-3fc4-e053-2a95a90abb45", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["b99b8309-dd80-422a-9b17-f20386dc4d8d"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "12 TABLET, FILM COATED in 1 BOTTLE (76420-053-12)", "package_ndc": "76420-053-12", "marketing_start_date": "20201024"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (76420-053-30)", "package_ndc": "76420-053-30", "marketing_start_date": "20201024"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "76420-053_b26ab5c7-62e8-3fc4-e053-2a95a90abb45", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "76420-053", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20261231"}